Gehlert DR - Search Results

1

Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain.

Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR. Morin SM, et al. Among authors: gehlert dr. Neuroscience. 1999;92(1):281-91. doi: 10.1016/s0306-4522(98)00732-5. Neuroscience. 1999. PMID: 10392850

2

Distribution of NPY Y5-like immunoreactivity in the rat brain.

Morin SM, Gehlert DR. Morin SM, et al. Among authors: gehlert dr. J Mol Neurosci. 2006;29(2):109-14. doi: 10.1385/JMN:29:2:109. J Mol Neurosci. 2006. PMID: 16954600

3

Characterization of [125I-Tyr0]-corticotropin releasing factor (CRF) binding to the CRF binding protein using a scintillation proximity assay.

Kahl SD, Liu XJ, Ling N, De Souza EB, Gehlert DR. Kahl SD, et al. Among authors: gehlert dr. J Neurosci Methods. 1998 Sep 1;83(2):103-11. doi: 10.1016/s0165-0270(98)00059-4. J Neurosci Methods. 1998. PMID: 9765123

4

Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.

Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, Shaw J, Fitz SD, Sajdyk TJ. Gehlert DR, et al. Eur J Pharmacol. 2005 Feb 21;509(2-3):145-53. doi: 10.1016/j.ejphar.2004.12.030. Eur J Pharmacol. 2005. PMID: 15733549

5

Effects of corticotropin-releasing factor 1 receptor antagonism on the hypothalamic-pituitary-adrenal axis of rodents.

Gehlert DR, Cramer J, Morin SM. Gehlert DR, et al. J Pharmacol Exp Ther. 2012 Jun;341(3):672-80. doi: 10.1124/jpet.111.189753. Epub 2012 Mar 8. J Pharmacol Exp Ther. 2012. PMID: 22402929

6

Differential distribution of neuropeptide Y Y1 and Y2 receptors in rat and guinea-pig brains.

Gehlert DR, Gackenheimer SL. Gehlert DR, et al. Neuroscience. 1997 Jan;76(1):215-24. doi: 10.1016/s0306-4522(96)00340-5. Neuroscience. 1997. PMID: 8971773

7

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.

Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW. Bymaster FP, et al. Among authors: gehlert dr. Neuropsychopharmacology. 2002 Nov;27(5):699-711. doi: 10.1016/S0893-133X(02)00346-9. Neuropsychopharmacology. 2002. PMID: 12431845

8

3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism.

Gehlert DR, Cippitelli A, Thorsell A, Lê AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J, Song M, McKinzie D, Morin M, Ciccocioppo R, Heilig M. Gehlert DR, et al. J Neurosci. 2007 Mar 7;27(10):2718-26. doi: 10.1523/JNEUROSCI.4985-06.2007. J Neurosci. 2007. PMID: 17344409 Free PMC article.

9

Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain.

Gehlert DR, Gackenheimer SL, Schober DA. Gehlert DR, et al. Neuroscience. 1991;44(2):501-14. doi: 10.1016/0306-4522(91)90073-w. Neuroscience. 1991. PMID: 1944896

10

Comparison of the distribution of binding sites for the potassium channel ligands [125I]apamin, [125I]charybdotoxin and [125I]iodoglyburide in the rat brain.

Gehlert DR, Gackenheimer SL. Gehlert DR, et al. Neuroscience. 1993 Jan;52(1):191-205. doi: 10.1016/0306-4522(93)90192-i. Neuroscience. 1993. PMID: 7679479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters